We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+1.85%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
–
AUM
$4.01B
AUM Growth
-$55.8M
Cap. Flow
-$77.9M
Cap. Flow %
-1.94%
Top 10 Hldgs %
16.78%
Holding
730
New
81
Increased
176
Reduced
283
Closed
57

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$32.1M
2
BMY icon
Bristol-Myers Squibb
BMY
+$28.3M
3
VZ icon
Verizon
VZ
+$26.7M
4
LOW icon
Lowe's Companies
LOW
+$25.6M
5
CMI icon
Cummins
CMI
+$20.9M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$38.5M
2
CL icon
Colgate-Palmolive
CL
+$31.6M
3
LLY icon
Eli Lilly
LLY
+$30.3M
4
HD icon
Home Depot
HD
+$28.5M
5
MSFT icon
Microsoft
MSFT
+$25.1M

Sector Composition

Rank Sector Weight
1 Healthcare 17.88%
2 Technology 13.15%
3 Financials 10.92%
4 Communication Services 10.03%
5 Industrials 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HPE icon
476
Hewlett Packard
HPE
$63.2B
$421K 0.01%
39,640
-13,678
-26% -$139K
EFAV icon
477
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.33B
$415K 0.01%
6,253
-17
-0.3% -$1.14K
HRC
478
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$414K 0.01%
8,215
– –
JNPR
479
DELISTED
Juniper Networks
JNPR
$412K 0.01%
18,322
-6,258
-25% -$146K
TAP icon
480
Molson Coors Class B
TAP
$7.76B
$412K 0.01%
4,078
– –
NICE icon
481
Nice
NICE
$5.82B
$407K 0.01%
6,369
– –
VNDA icon
482
Vanda Pharmaceuticals
VNDA
$303M
$405K 0.01%
36,190
+245
+0.7% +$2.37K
EMC
483
DELISTED
EMC CORPORATION
EMC
$405K 0.01%
14,902
+1,000
+7% +$27K
TBI
484
Trueblue
TBI
$213M
$404K 0.01%
21,355
-260,020
-92% -$5.43M
GIB icon
485
CGI
GIB
$15.1B
$399K 0.01%
9,350
– –
CFR icon
486
Cullen/Frost Bankers
CFR
$10.5B
$395K 0.01%
6,200
-250
-4% -$15.4K
AVB icon
487
AvalonBay Communities
AVB
$26.7B
$393K 0.01%
2,180
– –
PCAR icon
488
PACCAR
PCAR
$70B
$393K 0.01%
11,363
+330
+3% +$12.1K
CPHD
489
DELISTED
Cepheid Inc
CPHD
$392K 0.01%
12,755
+65
+0.5% +$1.97K
UTHR icon
490
United Therapeutics
UTHR
$25.9B
$391K 0.01%
3,695
-1,210
-25% -$135K
MDT icon
491
Medtronic
MDT
$109B
$386K 0.01%
4,452
+154
+4% +$12.5K
BGC
492
DELISTED
General Cable Corporation
BGC
$384K 0.01%
30,185
+385
+1% +$5.32K
AZ
493
DELISTED
Allianz Se Sponsored Adr Repstg 1/10 Ord Sh
AZ
$380K 0.01%
26,762
– –
RGEN icon
494
Repligen
RGEN
$8.01B
$376K 0.01%
13,755
+3,540
+35% +$90.5K
IBMF
495
DELISTED
iShares iBonds Sep 2017 Term Muni Bond ETF
IBMF
$375K 0.01%
13,706
+390
+3% +$10.7K
VE
496
DELISTED
VEOLIA ENVIRONNEMENT
VE
$373K 0.01%
17,249
– –
HZNP
497
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$370K 0.01%
22,485
+7,220
+47% +$117K
PZA icon
498
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.22B
$369K 0.01%
13,900
-135
-1% -$3.52K
IBMG
499
DELISTED
iShares iBonds Sep 2018 Term Muni Bond ETF
IBMG
$367K 0.01%
14,310
-4,640
-24% -$119K
MMP
500
DELISTED
Magellan Midstream Partners, L.P.
MMP
$361K 0.01%
4,750
+1,250
+36% +$88.7K
18 19
20
21 22

Similar funds

GVI
Green Valley Investors Wilmington, Delaware $1.76B AUM 5.64% 1-Year Est. Return
GMI
Greystone Managed Investments Regina, Saskatchewan, Canada $1.65B AUM 7.9% 1-Year Est. Return
CA
Cortland Advisers Wilmington, Delaware $2.18B AUM 8.82% 1-Year Est. Return
AWM
Ashmore Wealth Management Wilmington, Delaware $1.58B AUM 9.28% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
STMM
South Texas Money Management San Antonio, Texas $2.37B AUM 5.24% 1-Year Est. Return
RCM
Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

Boston Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, Boston Advisors held 730 positions worth $4.01B, down 1.4% from $4.06B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boston Advisors's Q2 2016 filing shows 81 new, 176 increased, 283 reduced and 57 closed positions. Its largest new stake was Sherwin-Williams: 204,480 shares worth $20M. The largest sale was AbbVie, an estimated $38.5M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

  • Boston Advisors's largest Q2 2016 buy was Sherwin-Williams: 204,480 shares worth $20M.
  • Boston Advisors added most to Biogen in Q2 2016, an estimated $32.1M increase.
  • Boston Advisors's biggest Q2 2016 reduction was AbbVie, cutting an estimated $38.5M.
  • Boston Advisors fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $23.4M.
  • Boston Advisors's ten largest holdings make up 17% of its $4.01B portfolio in Q2 2016.
  • Boston Advisors opened 81 new positions and closed 57 in Q2 2016.
  • Boston Advisors's portfolio value fell 1.4% quarter-over-quarter to $4.01B.

Based on Boston Advisors's 13F filing for Q2 2016, filed 26 Jul 2016.